Amneal Pharmaceuticals ended 2025 with strong financial results, exceeding management’s guidance in every key metric. With its sights set on continued growth in 2026, the company underscores its ongoing momentum in a competitive market.

Uber’s latest earnings surpassed the company’s own guidance for Q3, prompting questions about its future value. This article evaluates whether the rideshare pioneer is currently a buy, sell, or fairly priced.

Gentherm announced its 2025 third quarter results, declaring a record-high US$387 million in revenue. The thermal management leader secured US$745 million in new automotive awards and raised its revenue mid-point for the full year, signaling strong confidence in future growth.

Japan’s retail industry posted a slight uptick of 0.3% in July, according to a brief announcement. While few details are currently available, further information on factors driving this rise may be forthcoming.

Li Ning Company Limited has announced its 2025 interim results, focusing on a strategy of “Single Brand, Multi-Categories, Diversified Channels.” The company’s emphasis on professionalism and reinforced foundations highlights its commitment to sustained growth and innovation.